Description
XOFIGO RADIOPHARM
First action · last action
2016-10-01 · 2017-12-11
Transactions
2
First transaction's obligation
$400,000
Base + all options value (sum of deltas)
$302,784
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2202D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$400,000= $400,000
- Mod P000012017-12-11-$97,216= $302,784
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$400,000 | $400,000 | XOFIGO RADIOPHARM |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-12-11 | −$97,216 | $302,784 | XOFIGO RADIOPHARM |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V1EVGCK7XES8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0492 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $386,860 | FY2026 |
| 36C26226F0163 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $181,386 | FY2026 |
| 36C26026F0086 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $80,663 | FY2026 |
| 36C26126N0199 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $101,567 | FY2026 |
| 36C25626N0126 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $214,783 | FY2026 |
| 36E79725A0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
Other recipients under 6505 from 656-ST CLOUD VA MEDICAL CTR (00656) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26318F0224 | HERITAGE HEALTH SOLUTIONS, INC. | 656-ST CLOUD VA MEDICAL CTR (00656) | $3,498 | FY2018 |
| 36C26318F0057 | CSL BEHRING L.L.C. | 656-ST CLOUD VA MEDICAL CTR (00656) | $5,102 | FY2018 |
| 36C26318N0018 | CSL BEHRING L.L.C. | 656-ST CLOUD VA MEDICAL CTR (00656) | $24,405 | FY2018 |
| 36C26318N0004 | BAXALTA US INC. | 656-ST CLOUD VA MEDICAL CTR (00656) | $52,329 | FY2018 |
| VA26317J1625 | AMERICAN NATIONAL RED CROSS, THE | 656-ST CLOUD VA MEDICAL CTR (00656) | $884,044 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26316J1015_3600_V797P2202D_3600 · retrieved 2026-09-26.